HALOZYME THERAPEUTICS, INC. HALO 48.27
Health Care · NASDAQ · Data as of 2026-05-11
HALOZYME THERAPEUTICS, INC. (HALO) has delivered +28.3% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #990 of 1993 stocks overall and #108 of 264 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
48.27
Overall Rank
#990 / 1993
Sector Rank
#108 / 264
Revenue CAGR
+28.3%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio